Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...

Myelodysplastic syndrome (MDS) arises from defective blood stem cells that progressively lose their normal functions.

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...